Does Private Equity Have a Real-World Data Strategy?

Bolstered by private capital, modern healthcare marketing firms have looked to fill out service offerings in order to acquire market share. Their next big target could be real-world data expertise. Since bursting onto the pharma services scene several years back, private equity firms have catalyzed a new cohort of commercialization platforms, whose agency acquisition binges and remonetization deals have enabled scale. During this highly acquisitive period, their most sought-after subsegment has probably been the market access agency. With most of the payer-oriented shops accounted for — either having been scooped up by a PE-backed entity or one of the traditional strategics — RWD is emerging as a critical piece as the commercialization platforms seek to come to market in a more competitive way.

Read the full article: Does Private Equity Have a Real-World Data Strategy? //


Leave a Comment

Your email address will not be published.

Scroll to Top